SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (1908)2/19/1999 1:09:00 PM
From: Steve Harmon  Respond to of 2742
 
You would think a company with a market value of 22 cent a share would mention in a news release of last quarter's earnings that they received a payment of $3 million from IMNX. It equates to 13 cent a share in cash to Cistron.



To: Phil Cressman who wrote (1908)2/21/1999 11:33:00 AM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
"We have held exploratory discussions with several biotechnology and pharmaceutical companies regarding possible strategic alliances including joint ventures, mergers, or the sale of Cistron. These activities, begun in the Fall of 1997, have taken considerable time of both management and its financial advisor..."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News